From Wrist to Review: What High Quality ECG Data Means for Clinical Care

Bridging consumer technology and clinical care to empower earlier, smarter, and more connected health decisions.

The New Era of Continuous Care

Cardiovascular disease remains the world’s leading cause of death – a sober reminder that better prevention and management are essential. And achieving earlier intervention requires one thing above all: continuous visibility into the heart.

That capability is now being driven by growing consumer adoption of wearable health technology, which allows ECG monitoring to move beyond hospital walls.

According to B-Secur’s 2024 Market Report*, 69% of consumers who own a wearable use it daily, 75% track their health metrics like heart health, and 95% say they’d share data with their clinicians to better manage their heart health.

The sticking point, however, is that only 9% of healthcare providers report being “very satisfied” with current ECG diagnostic processes, signalling a clear gap between public enthusiasm and clinical trust.

Closing that gap depends on technology capable of delivering medical-grade accuracy in everyday life – technology that bridges the divide between consumer convenience and clinical confidence.

On-Demand Data Meets Real-World Impact

Once fitness accessories, today’s smart wearables – from watches to clothing to rings – are evolving into sophisticated health companions for anyone, no matter their age. Devices capable of delivering on-demand, medical-grade ECGs are becoming increasingly integrated into clinical care pathways, helping clinicians spot trends and intervene before complications escalate.

With each innovation, the line between consumer wearables and clinical tools continues to blur, reshaping how clinicians and patients interact with data, decisions, and care itself.

A powerful example of this transformation is unfolding in Florida, where Orlando Health has recently launched a wearable technology pilot program in partnership with WHOOP, Sensr, and B-Secur.

The initiative aims to improve patient care and reduce readmissions by equipping clinicians with live biometric data. Patients with chronic obstructive pulmonary disease (COPD) at Orlando Health South Lake Hospital are being discharged with WHOOP wristbands equipped with sensors that measure up to 50 metrics including heart rate, heart rate variability, oxygen saturation, temperature, and clinical-grade ECGs.

This data is then be monitored by outpatient care teams who can assess recovery in real time and intervene as needed, a model that exemplifies a future of proactive, data-driven care.

B-Secur’s Role: The Biometric Intelligence Behind the Shift

At the heart of this transformation lies biometric intelligence – the ability to capture, analyze, and interpret ECG signals with medical precision.

B-Secur’s FDA-cleared ECG software technology provides this capability, empowering healthcare partners, and device innovators to access validated insights that support chronic condition management, particularly in cardiovascular disease, where early detection is proven to save lives.

Unlike other ECG algorithms, B-Secur’s FDA-cleared technology, HeartKey, is engineered to maintain medical-grade signal quality in real-world conditions, filtering out motion noise, skin contact issues, and environmental interference that can obscure accurate readings frustrating clinicians and delaying diagnosis.

By supporting the Orlando Health pilot, B-Secur is helping demonstrate what’s possible when continuous biometric data meets clinical decision-making. Together with WHOOP and Sensr, we’re contributing to a model where technology augments clinical intuition and patients are supported long after they leave the hospital.

A Clinician’s Perspective: Data That Drives Action

For clinicians, the promise of on-demand ECG monitoring extends beyond data collection. The real value lies in actionable insights and information that helps clinicians intervene earlier, track recovery remotely, and prevent deterioration before it happens.

As Dr. Stephanie Dietz, Medical Director for Orlando Health’s Value-Based Care and Population Health, explains:

“This program will be an incredible asset to our providers since we’ll be able to see patients’ sleep patterns, movement, stress levels and more as they recover at home. This way, we can ensure we see critical changes in real-time and can arrange next steps for our patients right away, promoting a safe and speedier recovery.”

By combining WHOOP’s continuous data with B-Secur’s ECG-based software intelligence, clinicians can gain confidence in both the quality and relevance of the signals they see, ensuring insights translate into meaningful action.

Beyond COPD: The Broader Potential of On-Demand ECG Monitoring

While the Orlando Health pilot focuses on COPD, its implications extend across the spectrum of chronic disease management, from heart failure to hypertension.

On-demand monitoring provides the type of continuity that periodic visits can’t, connecting moments that would otherwise be missed between appointments. For health systems, that means earlier intervention, fewer re-admissions, and more efficient use of resources.

For patients, it means reassurance and empowerment: a chance to recover safely at home while staying connected to their care team through trusted data.

The Path Forward: From Wrist to Clinic

The phrase “from wrist to clinic” captures the essence of what’s happening in healthcare today – a seamless flow of trusted biometric data from everyday wearables into clinical environments where it can drive better outcomes.

For B-Secur, this is more than a milestone partnership; it’s a glimpse of the future we’re building here and now. A future where ECG insights don’t just monitor health but are increasingly informing, predicting, and protecting it.

B-Secur is proud to support Orlando Health, WHOOP, and Sensr in this pioneering program, helping bring continuous biometric insights into clinical care and shaping the next generation of personalized health intelligence. This is just the beginning.